Adolescents with chronic hepatitis C might be good candidates for direct‐acting antiviral therapy

Abstract

Abstract Three Japanese adolescents with chronic hepatitis C were treated by direct‐acting antivirals (DAAs). No adverse events or laboratory abnormalities were observed during and after DAA therapy, and a sustained virological response was achieved in all cases. The emotional functioning of the patients and their mothers were improved after DAA therapy.

Keywords

• adolescents
• chronic hepatitis C
• direct‐acting antivirals
• Japanese
• special population